List of Inovio Pharmaceuticals patents

List of Inovio Pharmaceuticals patents

List of Apexigen patents

List of Rubius Therapeutics patents

List of Rigel Pharmaceuticals patents

Companies in the Gym industry

List of companies in Black Sheep Capital's investment portfolio

Patents where

Current Assignee

Name

is

Inovio Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11291836 Minimally invasive dermal electroporation device		Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11291836	April 5, 2022
	‌ US Patent D987076 Hand-held electroporation device	Patent D987076 was granted and assigned to Inovio Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	D987076	May 23, 2023
	‌ US Patent 11291827 Electroporation device having a battery pack with power switch		Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11291827	April 5, 2022
	‌ US Patent 11331479 Device and method for single-needle in vivo electroporation	Patent 11331479 was granted and assigned to Inovio Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11331479	May 17, 2022
	‌ US Patent 11338028 Cancer vaccines targeting LEMD1 and uses thereof	Patent 11338028 was granted and assigned to Inovio Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11338028	May 24, 2022
	‌ US Patent 11338029 Cancer vaccines targeting PRAME and uses thereof		Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11338029	May 24, 2022
	‌ US Patent 11471675 Electroporation device and injection apparatus	Patent 11471675 was granted and assigned to Inovio Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11471675	October 18, 2022
	‌ US Patent 12064473 Cancer vaccines targeting Survivin and uses thereof	Patent 12064473 was granted and assigned to Inovio Pharmaceuticals on August, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	12064473	August 20, 2024
	‌ US Patent D1041653 Cap for a hand-held electroporation device	Patent D1041653 was granted and assigned to Inovio Pharmaceuticals on September, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	D1041653	September 10, 2024
	‌ US Patent 11565107 Tolerable and minimally invasive skin electroporation device	Patent 11565107 was granted and assigned to Inovio Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.		Inovio Pharmaceuticals		United States Patent and Trademark Office	11565107	January 31, 2023
	‌ US Patent 11684777 Method and device for minimally invasive in vivo transfection of adipose tissue using electroporation		Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11684777	June 27, 2023
	‌ US Patent 11883653 Electroporation device with detachable needle array with lock-out system	Patent 11883653 was granted and assigned to Inovio Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11883653	January 30, 2024
	‌ US Patent 12128229 Oral mucosal electroporation device and use thereof	Patent 12128229 was granted and assigned to Inovio Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	12128229	October 29, 2024
	‌ US Patent 11801288 Cancer vaccines and methods of treatment using the same	Patent 11801288 was granted and assigned to Inovio Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11801288	October 31, 2023
	‌ US Patent 11986517 Cancer vaccines targeting mesothelin and uses thereof	Patent 11986517 was granted and assigned to Inovio Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11986517	May 21, 2024
	‌ US Patent D1025355 Cap for a hand-held electroporation device	Patent D1025355 was granted and assigned to Inovio Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	D1025355	April 30, 2024
	‌ US Patent 11744885 Vaccines for recurrent respiratory papillomatosis and methods of using the same	Patent 11744885 was granted and assigned to Inovio Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.	Inovio Pharmaceuticals	Inovio Pharmaceuticals		United States Patent and Trademark Office	11744885	September 5, 2023

17 results

0 selected

17 results

0 selected